Research on a modified TNT regimen for high-risk rectal cancer reveals similar complete response rates and lower toxicity compared to traditional approaches.
PCA Rx & Cost Plus Drugs Partner to Transform Drug Pricing Transparency
What You Should Know: – PCA Rx and Cost Plus Drugs, are joining forces to tackle the longstanding issue of opaque and inflated drug pricing